[Influence of Specific Osteoporosis Drugs on Fracture Healing]

Overview

Journal Unfallchirurg

Date 2019 May 25

PMID 31123799

Citations 4

Authors

Eric Hesse

Carl Neuerburg

Christian Kammerlander

Ulla Stumpf

Richard Stange

Wolfgang Bocker

Affiliations

Soon will be listed here.

Abstract

Background: For the treatment of disturbed fracture healing, drugs could be given in addition to surgical procedures. Specific osteoporosis drugs affect the bone metabolism and are used to treat osteoporosis, particularly after a fragility fracture has occurred. Therefore, their use would be conceivable to improve a disturbed fracture healing.

Objective: This article presents the available and upcoming specific osteoporosis drugs and investigates whether these substances affect fracture healing in the context of osteoporosis. Furthermore, it is discussed whether disturbed fracture healing can be improved by the use of these substances.

Material And Methods: A literature search (PubMed) was conducted using key terms. Preclinical studies, clinical studies, reviews and meta-analyses were considered in order to present the current knowledge in a clinically relevant context.

Results: Preclinical and clinical studies show that specific osteoporosis drugs have no relevant negative impact on the healing of fragility fractures. A tendency to improve a disturbed fracture healing was attributed to bone anabolic substances; however, studies are inconsistent and there is no approval for this application.

Conclusion: Following a fragility fracture, osteoporosis should be diagnosed according to the guidelines and, if necessary, treated with specific osteoporosis drugs, since in principle they do not impair fracture healing but significantly reduce the risk of subsequent fractures. Approval to improve fracture healing requires further investigations.

Citing Articles

How relevant is lumbar bone mineral density for the stability of symphyseal implants? A biomechanical cadaver study.

Schwaabe F, Gleich J, Linhart C, Keppler A, Woiczinski M, Kammerlander C Eur J Trauma Emerg Surg. 2021; 48(4):3101-3108.

PMID: 34881391 PMC: 9360150. DOI: 10.1007/s00068-021-01850-6.

Assessment of Vitamin D Levels and Its Correlation With Osteoporosis and Fracture Site Comminution in Osteoporotic Hip Fractures in Tertiary Care Hospital.

Vellingiri K, Ethiraj P, S N, Shanthappa A, S J K Cureus. 2021; 13(1):e12982.

PMID: 33654639 PMC: 7916318. DOI: 10.7759/cureus.12982.

[62/f-unsteady walking and falls in the home environment : Preparation for the medical specialist examination-case 21].

Sauer D Orthopade. 2020; 50(Suppl 1):62-66.

PMID: 32990758 DOI: 10.1007/s00132-020-04004-5.

MiR-21 nanocapsules promote early bone repair of osteoporotic fractures by stimulating the osteogenic differentiation of bone marrow mesenchymal stem cells.

Sun X, Li X, Qi H, Hou X, Zhao J, Yuan X J Orthop Translat. 2020; 24:76-87.

PMID: 32695607 PMC: 7349941. DOI: 10.1016/j.jot.2020.04.007.

References

Takahashi N, Udagawa N, Suda T . A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun. 1999; 256(3):449-55. DOI: 10.1006/bbrc.1999.0252. View

Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J . Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem. 2005; 280(20):19883-7. DOI: 10.1074/jbc.M413274200. View

OLoughlin P, Cunningham M, Bukata S, Tomin E, Poynton A, Doty S . Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine (Phila Pa 1976). 2008; 34(2):121-30. DOI: 10.1097/BRS.0b013e318191e687. View

Aspenberg P, Genant H, Johansson T, Nino A, See K, Krohn K . Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2009; 25(2):404-14. DOI: 10.1359/jbmr.090731. View

Daugaard H, Elmengaard B, Andreassen T, Baas J, Bechtold J, Soballe K . The combined effect of parathyroid hormone and bone graft on implant fixation. J Bone Joint Surg Br. 2011; 93(1):131-9. PMC: 3681808. DOI: 10.1302/0301-620X.93B1.24261. View

Baron R, Hesse E . Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab. 2012; 97(2):311-25. PMC: 3275361. DOI: 10.1210/jc.2011-2332. View

Goldhahn J, Feron J, Kanis J, Papapoulos S, Reginster J, Rizzoli R . Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int. 2012; 90(5):343-53. DOI: 10.1007/s00223-012-9587-4. View

Adami S, Libanati C, Boonen S, Cummings S, Ho P, Wang A . Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. J Bone Joint Surg Am. 2012; 94(23):2113-9. DOI: 10.2106/JBJS.K.00774. View

Einhorn T, Gerstenfeld L . Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2014; 11(1):45-54. PMC: 4464690. DOI: 10.1038/nrrheum.2014.164. View

10.

Li Y, Cai H, Zhang Z . Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int. 2014; 26(2):431-41. DOI: 10.1007/s00198-014-2903-2. View

11.

Feng G, Chang-Qing Z, Yi-Min C, Xiao-Lin L . Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats. Int Immunopharmacol. 2014; 24(1):7-13. DOI: 10.1016/j.intimp.2014.11.010. View

12.

Molvik H, Khan W . Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int. 2015; 26(4):1251-60. DOI: 10.1007/s00198-014-3007-8. View

13.

Yee C, Xie L, Hatsell S, Hum N, Murugesh D, Economides A . Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model. Bone. 2015; 82:122-34. PMC: 4635060. DOI: 10.1016/j.bone.2015.04.048. View

14.

Liu Y, Rui Y, Cheng T, Huang S, Xu L, Meng F . Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats. Calcif Tissue Int. 2015; 98(3):263-74. DOI: 10.1007/s00223-015-0085-3. View

15.

Yoo J, Moon S, Ha Y, Lee D, Gong H, Park S . Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab. 2015; 22(4):175-81. PMC: 4691591. DOI: 10.11005/jbm.2015.22.4.175. View

16.

Kates S, Ackert-Bicknell C . How do bisphosphonates affect fracture healing?. Injury. 2016; 47 Suppl 1:S65-8. PMC: 4739649. DOI: 10.1016/S0020-1383(16)30015-8. View

17.

Black D, Rosen C . Clinical Practice. Postmenopausal Osteoporosis. N Engl J Med. 2016; 374(3):254-62. DOI: 10.1056/NEJMcp1513724. View

18.

Pisani P, Renna M, Conversano F, Casciaro E, Di Paola M, Quarta E . Major osteoporotic fragility fractures: Risk factor updates and societal impact. World J Orthop. 2016; 7(3):171-81. PMC: 4794536. DOI: 10.5312/wjo.v7.i3.171. View

19.

Lou S, Lv H, Wang G, Zhang L, Li M, Li Z . The Effect of Teriparatide on Fracture Healing of Osteoporotic Patients: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2016; 2016:6040379. PMC: 4939202. DOI: 10.1155/2016/6040379. View

20.

Cosman F, Crittenden D, Adachi J, Binkley N, Czerwinski E, Ferrari S . Romosozumab Treatment in Postmenopausal Women with Osteoporosis. N Engl J Med. 2016; 375(16):1532-1543. DOI: 10.1056/NEJMoa1607948. View